Edition:
India

Celon Pharma SA (CLNP.WA)

CLNP.WA on Warsaw Stock Exchange

43.50PLN
16 Oct 2019
Change (% chg)

0.20zł (+0.46%)
Prev Close
43.30zł
Open
43.25zł
Day's High
43.95zł
Day's Low
43.20zł
Volume
2,991
Avg. Vol
10,251
52-wk High
51.10zł
52-wk Low
28.25zł

Latest Key Developments (Source: Significant Developments)

Celon Pharma Says Receives Patent From Japanese Patent Office Regarding Inhibitory FGFR
Monday, 23 Sep 2019 

Sept 23 (Reuters) - Celon Pharma SA ::SAYS RECEIVES PATENT FROM JAPANESE PATENT OFFICE REGARDING INHIBITORY FGFR AND ITS USE IN ONCOLOGICAL TREATMENTS AND MEDICINAL PRODUCTS.  Full Article

Celon Pharma Plans FY 2018 Dividend Of 0.24 Zloty/Shr
Friday, 22 Mar 2019 

March 22 (Reuters) - Celon Pharma SA ::MANAGEMENT RECOMMENDS FY 2018 DIVIDEND OF 0.24 ZLOTYPER SHARE.  Full Article

Celon Pharma Gets Patent For PDE10A Inhibitors In China
Friday, 8 Mar 2019 

March 8 (Reuters) - Celon Pharma SA ::SAID ON THURSDAY IT HAS BEEN GRANTED PATENT FOR PHOSPHODIESTERASE 10A INHIBITORS (PDE10A) BY CHINA NATIONAL INTELLECTUAL PROPERTY ADMINISTRATION (CNIPA).DEVELOPMENT OF THE INHIBITOR IN PATIENTS SUFFERING FROM PSYCHOTIC DISORDERS, INCLUDING SCHIZOPHRENIA, IS IMPLEMENTED UNDER NOTESZHD PROJECT IN THE STRATEGMED PROGRAM.THE PROJECT IS IN PHASE I OF CLINICAL TRIALS.  Full Article

Celon Pharma Registers Salmex In Czech Republic, Slovakia
Monday, 1 Oct 2018 

Oct 1 (Reuters) - CELON PHARMA SA ::SAYS RECEIVED INFORMATION ABOUT POSITIVE COMPLETION OF MUTUAL RECOGNITION PROCESS FOR 'SALMEX' DRUG FOR CZECH AND SLOVAKIAN MARKETS.AFTER COMPLETION OF THE PROCEDURE, BOTH COUNTRIES WILL VERIFY DOMESTIC VERSIONS OF PRINT MATERIALS AND ISSUE DECISIONS REGARDING ADMISSION TO TRADE WITHIN TIMELINES AS PER LEGISLATION PROCEDURES.SAYS ESTIMATED TIME OF LAUNCHING THE PRODUCT IS Q1 2019.  Full Article

Celon Pharma H1 Net Profit Rises To 15.1 Million Zlotys
Tuesday, 25 Sep 2018 

Sept 25 (Reuters) - Celon Pharma SA ::H1 NET PROFIT 15.1 MILLION ZLOTYS VERSUS 13.4 MILLION ZLOTYS YEAR AGO.H1 REVENUE 58.4 MILLION ZLOTYS VERSUS 57.0 MILLION ZLOTYS YEAR AGO.H1 OPERATING PROFIT 17.3 MILLION ZLOTYS VERSUS 12.8 MILLION ZLOTYS YEAR AGO.  Full Article

Celon Pharma Q1 Net Profit Rises To 7.5 Million Zlotys
Tuesday, 15 May 2018 

May 15 (Reuters) - Celon Pharma SA ::Q1 REVENUE 28.2 MILLION ZLOTYS VERSUS 28.4 MILLION ZLOTYS YEAR AGO.Q1 NET PROFIT 7.5 MILLION ZLOTYS VERSUS 5.0 MILLION ZLOTYS YEAR AGO.  Full Article

Celon Pharma Plans FY 2017 Dividend Of 0.17 Zloty/Share
Monday, 7 May 2018 

May 7 (Reuters) - CELON PHARMA SA ::MANAGEMENT PROPOSES FY 2017 DIVIDEND OF 0.17 ZLOTY PER SHARE.  Full Article

Celon Pharma Supervisory Board Chairman Resigns
Wednesday, 3 Jan 2018 

Jan 3 (Reuters) - CELON PHARMA SA ::MACIEJ ANDRZEJ KRASINSKI RESIGNS FROM HIS POST AS CHAIRMAN OF CO'S SUPERVISORY BOARD.  Full Article

Celon Pharma To Get PLN 24.7 Mln Financing For Development Of Biosimilar Drug
Wednesday, 13 Dec 2017 

Dec 13 (Reuters) - CELON PHARMA SA ::SIGNS AGREEMENT FOR FUNDING OF ITS PROJECT WITH NATIONAL CENTRE FOR RESEARCH AND DEVELOPMENT.UNDER AGREEMENT TO GET PLN 24.7 MILLION FINANCING FOR DEVELOPMENT OF BIOSIMILAR DRUG BASED ON FAB FRAGMENT.  Full Article

Celon Pharma Plans To Place Salmex On Scandinavian Markets In H1 2018
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - CELON PHARMA SA ::INFORMS THAT REGISTRATION PROCEDURE OF SALMEX DRUG IN SCANDINAVIAN COUNTRIES ENDS POSITIVELY.ESTIMATES THAT WILL PLACE SALMEX ON SCANDINAVIAN MARKETS IN H1 2018.  Full Article